Cargando…
IgG4-related Disease Emerging after COVID-19 mRNA Vaccination
A 78-year-old Japanese woman with no history of rheumatic disease received 2 doses of the BNT162b2 COVID-19 mRNA vaccine. Two weeks later, she noticed bilateral swelling in the submandibular region. Blood tests showed hyper-immunoglobulin (Ig)G4emia, and (18)F-fluorodeoxyglucose (FDG)-positron emiss...
Autores principales: | Aochi, Satsuki, Uehara, Masaaki, Yamamoto, Motohisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258086/ https://www.ncbi.nlm.nih.gov/pubmed/36889713 http://dx.doi.org/10.2169/internalmedicine.1125-22 |
Ejemplares similares
-
The differential diagnosis of IgG4-related disease based on machine learning
por: Yamamoto, Motohisa, et al.
Publicado: (2022) -
Post-COVID mRNA-vaccine IgG4 shift: worrisome?
por: Kadkhoda, Kamran
Publicado: (2023) -
Clinical Questions and an Inquiring Mind for Patients with IgG4-related Disease
por: Yamamoto, Motohisa, et al.
Publicado: (2018) -
Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021) -
Human IgG and IgA responses to COVID-19 mRNA vaccines
por: Wisnewski, Adam V., et al.
Publicado: (2021)